Herbas VPB

Print
EN | LT
LT - Apoptozę sukeliantys agentai, skirti vėžio ir imuninių bei autoimuninių ligų gydymui
EN - APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 471/04 (2006.01)
A61K 31/437 (2006.01)
A61K 35/00 (2006.01)
European patent
(11) Number of the document 2576546
(13) Kind of document T
(96) European patent application number 10784398.9
Date of filing the European patent application 2010-11-22
(97) Date of publication of the European application 2013-04-10
(45) Date of publication and mention of the grant of the patent 2015-07-22
(46) Date of publication of the claims translation 2015-09-25
PCT application
(86) Number PCT/US2010/057587
Date 2010-11-22
PCT application publication
(87) Number WO 2011/149492
Date 2011-12-01
Priority applications
(30) Number Date Country code
787682 2010-05-26 US
Inventors
(72)
BRUNCKO, Milan, US
DING, Hong, US
DOHERTY, George, US
ELMORE, Steven, US
HASVOLD, Lisa, US
HEXAMER, Laura, US
KUNZER, Aaron R., US
SONG, Xiaohong, US
SOUERS, Andrew, J., US
SULLIVAN, Gerard, US
TAO, Zhi-Fu, US
WANG, Gary, T., US
WANG, Le, US
WANG, Xilu, US
WENDT, Michael, US
MANTEI, Robert, US
HANSEN, Todd, M., US
Grantee
(73) AbbVie Bahamas Ltd., Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau, BS
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Apoptozę sukeliantys agentai, skirti vėžio ir imuninių bei autoimuninių ligų gydymui
  APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
Last renewal fee
Payment date Validity (years) Amount
2020-11-12 11 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2021-11-22